Cargando…
Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis Treatments
Intrathecal IgG synthesis is a key biological feature of multiple sclerosis (MS). When acquired early, it persists over time. A growing body of evidence suggests that intrathecal Ig-secreting cells may be pathogenic either by a direct action of toxic IgG or by locally secreting bystander toxic produ...
Autor principal: | Bonnan, Mickael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4306411/ https://www.ncbi.nlm.nih.gov/pubmed/25653878 http://dx.doi.org/10.1155/2015/296184 |
Ejemplares similares
-
Estimation of intrathecal IgG synthesis: simulation of the risk of underestimation
por: Bonnan, Mickael, et al.
Publicado: (2018) -
Does Disease-Irrelevant Intrathecal Synthesis in Multiple Sclerosis Make Sense in the Light of Tertiary Lymphoid Organs?
por: Bonnan, Mickael
Publicado: (2014) -
The Sexual Dimorphism in Cerebrospinal Fluid Protein Content Does Not Affect Intrathecal IgG Synthesis in Multiple Sclerosis
por: Castellazzi, Massimiliano, et al.
Publicado: (2022) -
Single-cell transcriptomics combined with proteomics of intrathecal IgG reveal transcriptional heterogeneity of oligoclonal IgG-secreting cells in multiple sclerosis
por: Polak, Justyna, et al.
Publicado: (2023) -
Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis
por: Schwenkenbecher, Philipp, et al.
Publicado: (2017)